Focal Neuropathies

Volume 201
Erscheinungsjahr 2024
ISBN: 978-0-323-90108-6
Verlag: Elsevier Science

Buch, Englisch, 312 Seiten, Format (B × H): 192 mm x 262 mm

Facial Neuropathies, Volume 202 summarizes research and treatment on focal neuropathies to update clinicians on nerve biology and new diagnostic techniques to guide investigation and treatment of mononeuropathies. The book explores research broadly applicable to all types of mononeuropathies as well as individual mononeuropathy syndromes. Chapters on individual mononeuropathies include anatomy, causes, controversial diagnoses, and current or potential future treatments.

Autoren/Hrsg.

Weitere Mitwirkende

Chalk, Colin

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft

Inhaltsverzeichnis

1. Hallmarks of peripheral nerve injury and regeneration
2. The role of imaging in focal neuropathies
3. The role of electrodiagnosis in focal neuropathies
4. Carpal tunnel syndrome
5. Other median neuropathies
6. Ulnar neuropathy
7. Radial neuropathy
8. Axillary and musculocutaneous neuropathies
9. Fibular (peroneal) neuropathy
10. Sciatic and tibial neuropathies
11. Femoral and obturator neuropathies
12. Meralgia paresthetica
13. Piriformis syndrome
14. Surgery for mononeuropathies
15. Peripheral nerve tumors
16. Focal inflammatory neuropathies

Über Autor(innen)

Chalk, Colin
Colin Chalk graduated from McGill University (MD,CM 1984), trained in neurology at Mayo Clinic and Oxford University, and completed a fellowship in peripheral nerve diseases at Mayo Clinic. He returned to McGill in 1991. From 2004 to 2019 he was the Director of the Division of Neurology, Montréal General Hospital. He runs peripheral neuropathy and myasthenia gravis clinics at the Montréal General Hospital, and is in charge of the Montréal General's EMG laboratory. He also has a major administrative and teaching role in the McGill Faculty of Medicine's undergraduate medical curriculum. His scholarly work in neuromuscular disease includes several Cochrane reviews, participation in multicentre clinical trials, and papers on clinical aspects of neuromuscular disease.